Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs PT Telekomunikasi Indonesia Tbk (TLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs PT Telekomunikasi Indonesia Tbk — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $109.88 (market cap $12.58B), while PT Telekomunikasi Indonesia Tbk trades at $12.86 (market cap $12.75B). The key difference: Halozyme Therapeutics Inc. Common Stock and PT Telekomunikasi Indonesia Tbk are close in size by market cap, and PT Telekomunikasi Indonesia Tbk pays a 9.37% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and PT Telekomunikasi Indonesia Tbk for 0 Days on average.
| HALO | TLK | |
|---|---|---|
Market Cap | $12.58B | $12.75B |
Volume | 2,179,278 | 1,019,905 |
Sector | Health | Media |
52-Week High | $115.22 | $23.43 |
52-Week Low | $61.63 | $12.42 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $14.11B |
Dividend Yield | — | 9.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About PT Telekomunikasi Indonesia Tbk
Telkom Indonesia provides mobile, fixed-line, broadband, and digital services in Indonesia. Its businesses include Telkomsel, which serves the country’s mobile market.
Read more on TLK →
